REFERENCES
- Monboisse J. C., Garnotel R., Bellon G., et al, 1994. The alpha 3 chain of type IV collagen prevents activation of human polymorphonuclear leukocytes. J. Biol. Chem.. 269: 25475–25482. [PUBMED], [INFOTRIEVE]
- Han J., Ohno N., Pasco S., Monboisse J. C., Borel J. P., Kefalides N. A.. 1997. A cell binding domain from the alpha3 chain of type IV collagen inhibits proliferation of melanoma cells. J. Biol. Chem.. 272: 20395–20401. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shahan T. A., Ohno N., Pasco S., Borel J. P., Monboisse J. C., Kefalides N. A.. 1999. Inhibition of tumor cell proliferation by type IV collagen requires increased levels of cAMP. Conn. Tiss. Res.. 40: 221–232
- Shahan T. A., Ziaie Z., Pasco S., et al, 1999. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells. Cancer Res.. 59: 4584–4590. [PUBMED], [INFOTRIEVE]
- Pasco S., Han J., Gillery G., et al, 2000. A specific sequence of the noncollagenous domain of the alpha3(IV) chain of type IV collagen inhibits expression and activation of matrix metalloproteinases by tumor cells. Cancer Res.. 60: 467–473. [PUBMED], [INFOTRIEVE]
- Shahan T. A., Fawzi A., Bellon G., Monboisse J. C., Kefalides N. A.. 2000. Regulation of tumor cell chemotaxis by type IV collagen is mediated by a Ca(2+)-dependent mechanism requiring CD47 and the integrin alpha(V)beta(3). J. Biol. Chem.. 275: 4796–4802. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Maeshima Y., Manfredi M., Reimer C., Holthaus K. A., Hopfer Chandamuri B.R., Kharbanda S., Kalluri R.. 2001. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J. Biol. Chem.. 276: 15240–15248. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Maeshima Y., Yeramalla U. L., Dhanabal M., Holthaus K. A., Barbashov S., Kharbanda S., Reimer C., Manfredi M., Dickerson W. M., Kalluri R.. 2001. Extracellular matrix-derived peptide binds to α vβ 3 and inhibits angiogenesis. J. Biol. Chem.. 276: 31959–31968. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hynes R. O.. 2002. Commentary: A reevaluation of integrins as regulators of angiogenesis. Nature Med.. 8: 918–921. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hudson B. G., Tryggvason K., Sundaramoorthy M., Neilson E. G.. 2003. Alport's syndrome, Goodpasture's syndrome and type IV collagen. N. Engl. J. Med.. 348: 2543–2556. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kefalides N. A., Alper R. A.. 1988. Structure and organization of macromolecules in basement membranes. Collagen, Nimni M. E.. Vol. II: pp. 74–94, Boca Raton, FL, CRC Press
- Haas T. L., Madri J. A.. 1999. Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: Implications for angiogenesis. Trends Cardiovasc. Med.. 9: 70–77. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Liotta L. A., Steeg P. S., Stetler-Stevenson W. G.. 1991. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell. 64: 327–336. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Folkman J.. 1992. Angiogenesis. Seminars Cancer Biol.. 3: 65–71
- O'Reilly M. S., Holmgren L., Shing Y., et al, 1994. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 79: 315–328. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Weinstat-Saslow D., Steeg P. S.. 1994. Angiogenesis and colonization in the tumor metastatic process: Basic and applied advances. FASEB J.. 8: 401–407. [PUBMED], [INFOTRIEVE]
- Folkman J., Shing Y.. 1992. Angiogenesis. J. Biol. Chem. 267: 10931–10934. [PUBMED], [INFOTRIEVE]
- Weidner N., Folkman J., Pozza F., et al, 1992. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst.. 84: 1875–1887. [PUBMED], [INFOTRIEVE]
- Kleinman H. K., McGarvey M. L., Liotta L. A., Robey P. G., Tryggvason K., Martin G. R.. 1986. Isolation and characterization of type IV procollagen, laminin, and heparin sulfate proteoglycan from the EHS sarcoma. Biochemistry. 24: 6188–6193
- Kefalides N. A., Ohno N., Wilson C. B., Fillit H., Zabriski J., Rosenbloom J.. 1993. Identification of antigenic epitopes in type IV collagen by use of synthetic peptides. Kidney Int.. 43: 94–100. [PUBMED], [INFOTRIEVE]
- Barany G., Merrifield R. B.. 1980; The Peptides. Vol. II, Gross E., Meinhofer J., pp. 1–284, New York, Academic Press
- Feng L., Xia Y., Wilson C. B.. 1994. Identification of antigenic epitopes in type IV collagen by use of synthetic peptides. J. Biol. Chem.. 269: 2342–2348. [PUBMED], [INFOTRIEVE]
- Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R.. 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest.. 52: 2745–2756. [PUBMED], [INFOTRIEVE]
- Gimbrone M. A., Jr., Cotran R. S., Folkman J.. 1974. Human vascular endothelial cells in culture. Growth and DNA synthesis. J. Cell. Biol.. 60: 673–684. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Maciag T., Cerundolo J., Ilsley S., Kelley P. R., Forand R.. 1979. An endothelial cell growth factor from bovine hypothalamus: Identification and partial characterization. Proc. Natl. Acad. Sci. USA. 76: 5674–5678. [PUBMED], [INFOTRIEVE]
- Grant D. S., Kinsella J. L., Kibbey M. C., et al, 1995. Matrigel induces thymosin beta 4 gene in differentiating endothelial cells. J. Cell Sci.. 108: 3685–3694. [PUBMED], [INFOTRIEVE]
- Grant D. S., Kinsella J. L., Fridman R., et al, 1992. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J. Cellular Phys.. 153: 614–625
- Ahmed S. A., Gogal R. M., Walsh J. E.. 1994. A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: An alternative to [3H]thymidine incorporation assay. J. Immunol. Meth.. 170: 211–224. [CROSSREF]
- Nicosia R. F., Lin Y. J., Hazelton D., Qian X.. 1997. Endogenous regulation of angiogenesis in the rat aorta model. Role of vascular endothelial growth factor. Am. J. Pathol.. 151: 1379–1386. [PUBMED], [INFOTRIEVE]
- Dowdy S., Wearden S.. 1983; Statistics for Research, R. A., Bradley, J. S., Hunter, D. G., Kendall, R. G., Miller, G. S., Watson, pp. 32–38, New York, John Wiley and Sons
- Auerbach R., Kubai L., Knighton D., Folkman J.. 1974. A simple procedure for the long-term cultivation of chicken embryos. Dev. Biol.. 41: 391–394. [PUBMED], [INFOTRIEVE]
- Powell J. A., Mohamed S. N., Kerr J. S., Mousa S.. 2000. Antiangiogenesis efficacy of nitric oxide donors. J. Cell. Biochem.. 80: 104–114. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Eble J. A., Ries A., Lichy A., Mann K., et al, 1996. The recognition sites of the integrins alpha1beta1 and alpha2beta1 within collagen IV are protected against gelatinase A attack in the native protein. J. Biol. Chem.. 271: 30964–30970. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Golbik R., Eble J. A., Ries A., Kuhn K.. 2000. The spatial orientation of the essential amino acid residues arginine and aspartate within the alpha1beta1 integrin recognition site of collagen IV has been resolved using fluorescence resonance energy transfer. J. Mol. Biol.. 24: 501–509. [CROSSREF]
- Reinhold M. I., Green J. M., Lindberg F. P., Ticchioni M., Brown E. J.. 1999. Cell spreading distinguishes the mechanism of augmentation of T cell activation by integrin-associated protein/CD47 and CD28. Int. Immunol.. 11: 707–718. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hermann P., Armant M., Brown E. J., et al, 1999. The vitronectin receptor and its associated CD47 molecule mediates proinflammatory cytokine synthesis in human monocytes by interaction with soluble CD23. J. Cell Biol.. 11 Vol., 144: 767–775. [CROSSREF]
- Cooper D., Lindberg F. P., Gamble J. R., Brown E. J., Vadas M. A.. 1995. Transendothelial migration of neutrophils involves integrin-associated protein (CD47). Proc. Natl. Acad. Sci. USA. 92: 3978–3982. [PUBMED], [INFOTRIEVE]
- Brooks P. C., Montgomery A. M., et al, 1994. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell. 79: 1157–1164. [PUBMED], [INFOTRIEVE], [CROSSREF]